2023
DOI: 10.1126/sciadv.adf4098
|View full text |Cite
|
Sign up to set email alerts
|

Polydopamine-based nanomedicines for efficient antiviral and secondary injury protection therapy

Abstract: Viral infections continue to threaten human health. It remains a major challenge to efficiently inhibit viral infection while avoiding secondary injury. Here, we designed a multifunctional nanoplatform (termed as ODCM), prepared by oseltamivir phosphate (OP)–loaded polydopamine (PDA) nanoparticles camouflaged by the macrophage cell membrane (CM). OP can be efficiently loaded onto the PDA nanoparticles through the π-π stacking and hydrogen bonding interactions with a high drug-loading rate of 37.6%. In particul… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 13 publications
(1 citation statement)
references
References 52 publications
0
1
0
Order By: Relevance
“…Several reports are on the antitumor effects of BP-based drug delivery systems. However, these nanocarriers are primarily loaded with small-molecule drugs and nucleotides instead of bioactive macromolecules. In addition, polydopamine is most widely used for drug delivery applications, including photothermal and targeted therapies. Nevertheless, immunotherapy and PTT can synergistically inhibit tumor cells using multiple mechanisms, such as improving ferroptosis for synergistic photothermal-IDO immunotherapy. , …”
Section: Introductionmentioning
confidence: 99%
“…Several reports are on the antitumor effects of BP-based drug delivery systems. However, these nanocarriers are primarily loaded with small-molecule drugs and nucleotides instead of bioactive macromolecules. In addition, polydopamine is most widely used for drug delivery applications, including photothermal and targeted therapies. Nevertheless, immunotherapy and PTT can synergistically inhibit tumor cells using multiple mechanisms, such as improving ferroptosis for synergistic photothermal-IDO immunotherapy. , …”
Section: Introductionmentioning
confidence: 99%